Bluesphere Bio, Inc
Clinical trials sponsored by Bluesphere Bio, Inc, explained in plain language.
-
New cell therapy aims to stop blood cancers from coming back
Disease control Recruiting nowThis early-phase trial tests a new cell therapy called BSB-1001 in 38 adults with high-risk blood cancers (AML, ALL, or MDS) who have had a stem cell transplant. The therapy uses specially modified immune cells to target and kill cancer cells that may remain, with the goal of pre…
Phase: PHASE1, PHASE2 • Sponsor: BlueSphere Bio, Inc • Aim: Disease control
Last updated May 26, 2026 11:54 UTC
-
New cell therapy aims to stop blood cancer relapse in tough-to-treat patients
Disease control Recruiting nowThis early-stage trial tests a new cell therapy called BSB-2002 in adults with a specific form of acute myeloid leukemia (AML) that has returned or not responded to at least two prior treatments. The main goal is to check the safety of BSB-2002 and see if it can prevent the cance…
Phase: PHASE1 • Sponsor: BlueSphere Bio, Inc • Aim: Disease control
Last updated May 26, 2026 10:35 UTC